Virtual care for multiple myeloma in the COVID-19 era: interrupted time series analysis of veterans health administration data.
作者信息
Su Christopher T, Chen Jason C, Sussman Jeremy B
机构信息
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA.
出版信息
Leuk Lymphoma. 2023 May;64(5):1035-1039. doi: 10.1080/10428194.2023.2189989. Epub 2023 Mar 16.
Abstract
摘要
相似文献
1
Virtual care for multiple myeloma in the COVID-19 era: interrupted time series analysis of veterans health administration data.COVID-19 时代多发性骨髓瘤的虚拟护理：退伍军人健康管理数据的中断时间序列分析
Leuk Lymphoma. 2023 May;64(5):1035-1039. doi: 10.1080/10428194.2023.2189989. Epub 2023 Mar 16.
2
A retrospective analysis of factors impacting survival in United States military veterans with multiple myeloma.对影响美国多发性骨髓瘤退伍军人生存因素的回顾性分析。
Leuk Lymphoma. 2024 Apr;65(4):530-533. doi: 10.1080/10428194.2023.2295791. Epub 2023 Dec 26.
3
Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.橙剂暴露与意义未明的单克隆丙种球蛋白血症：一项牧场工人行动退伍军人队列研究。
JAMA Oncol. 2015 Nov;1(8):1061-8. doi: 10.1001/jamaoncol.2015.2938.
4
Differential Impact of COVID-19 on the Use of Tele-mental Health Among Veterans Living in Urban or Rural Areas.新冠疫情对城乡退伍军人使用远程心理健康服务的不同影响。
Psychiatr Serv. 2022 Dec 1;73(12):1393-1396. doi: 10.1176/appi.ps.202100363. Epub 2022 Jun 2.
5
Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System.验证算法以选择国家退伍军人事务医疗保健系统中的多发性骨髓瘤患者和开始骨髓瘤治疗的患者。
Pharmacoepidemiol Drug Saf. 2023 May;32(5):558-566. doi: 10.1002/pds.5579. Epub 2022 Dec 28.
6
Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans.老年人多发性骨髓瘤的脆弱性：一项对美国退伍军人的研究。
JCO Clin Cancer Inform. 2020 Feb;4:117-127. doi: 10.1200/CCI.19.00094.
7
Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma.定义老年美国退伍军人多发性骨髓瘤新治疗后的多种合并症及其影响。
J Natl Cancer Inst. 2021 Aug 2;113(8):1084-1093. doi: 10.1093/jnci/djab007.
8
Multiple myeloma and diagnostic imaging.多发性骨髓瘤与诊断性影像学
Radiol Technol. 2014 Mar-Apr;85(4):391-410; quiz 411-3.
9
What Is Multiple Myeloma?什么是多发性骨髓瘤？
JAMA. 2022 Feb 1;327(5):497. doi: 10.1001/jama.2021.25306.
10
Conducting health services research during the COVID-19 pandemic: experiences from the veterans health administration.在 COVID-19 大流行期间开展卫生服务研究：退伍军人健康管理局的经验。
BMC Health Serv Res. 2023 Nov 16;23(1):1267. doi: 10.1186/s12913-023-10296-y.
引用本文的文献
1
Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter study.基于伊沙佐米的一线治疗，随后对新诊断的体弱老年多发性骨髓瘤患者进行伊沙佐米维持治疗：一项前瞻性多中心研究。
EClinicalMedicine. 2024 Jan 25;68:102431. doi: 10.1016/j.eclinm.2024.102431. eCollection 2024 Feb.
本文引用的文献
1
Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period.新冠疫情早期多发性骨髓瘤治疗模式的变化
Leukemia. 2022 Aug;36(8):2136-2139. doi: 10.1038/s41375-022-01633-x. Epub 2022 Jun 27.
2
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States.COVID-19 大流行对美国转移性实体瘤患者治疗模式的影响。
J Natl Cancer Inst. 2022 Apr 11;114(4):571-578. doi: 10.1093/jnci/djab225.
3
Digital Health for Patients With Multiple Myeloma: An Unmet Need.多发性骨髓瘤患者的数字健康：未满足的需求。
JCO Clin Cancer Inform. 2021 Oct;5:1096-1105. doi: 10.1200/CCI.20.00145.
4
Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions.使用自回归求和移动平均 (ARIMA) 模型的中断时间序列分析：评估大规模卫生干预措施的指南。
BMC Med Res Methodol. 2021 Mar 22;21(1):58. doi: 10.1186/s12874-021-01235-8.
5
Forecasting the dynamics of cumulative COVID-19 cases (confirmed, recovered and deaths) for top-16 countries using statistical machine learning models: Auto-Regressive Integrated Moving Average (ARIMA) and Seasonal Auto-Regressive Integrated Moving Average (SARIMA).使用统计机器学习模型（自回归积分移动平均模型（ARIMA）和季节性自回归积分移动平均模型（SARIMA））预测16个主要国家的新冠累计病例（确诊、康复和死亡）动态。
Appl Soft Comput. 2021 May;103:107161. doi: 10.1016/j.asoc.2021.107161. Epub 2021 Feb 8.
6
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.与 COVID-19 多发性骨髓瘤患者结局相关的临床特征：国际骨髓瘤学会数据集的初步结果。
Blood. 2020 Dec 24;136(26):3033-3040. doi: 10.1182/blood.2020008150.
7
Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma.老年人多发性骨髓瘤新诊断患者的治疗负担。
Clin Lymphoma Myeloma Leuk. 2021 Feb;21(2):e152-e159. doi: 10.1016/j.clml.2020.09.010. Epub 2020 Oct 1.
8
Telehealth for Cancer Care in Veterans: Opportunities and Challenges Revealed by COVID.新冠疫情揭示了退役军人癌症治疗远程医疗的机遇与挑战
JCO Oncol Pract. 2021 Jan;17(1):22-29. doi: 10.1200/OP.20.00520. Epub 2020 Sep 24.
9
Management of multiple myeloma during COVID-19 pandemic.COVID-19大流行期间多发性骨髓瘤的管理
Leuk Res Rep. 2020 Jun 13;14:100212. doi: 10.1016/j.lrr.2020.100212. eCollection 2020.
10
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN).COVID-19 大流行时代多发性骨髓瘤患者的管理：来自欧洲骨髓瘤网络（EMN）的共识文件。
Leukemia. 2020 Aug;34(8):2000-2011. doi: 10.1038/s41375-020-0876-z. Epub 2020 May 22.
Zotero 插件